JACQUELINE PEREZ: Open Payments
NPI 1871067199 · CLEBURNE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$581 in 30 payments from 15 companies in 2025. Trend: 2023 $24 · 2024 $444 · 2025 $581
Food & beverage: $512Education: $69
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $167 |
| Exact Sciences Corporation | 4 | $71 |
| Lundbeck LLC | 3 | $50 |
| Corium, LLC | 2 | $45 |
| Ardelyx, Inc. | 2 | $41 |
| Novo Nordisk Inc | 2 | $35 |
| Lilly USA, LLC | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: Veozah, REXULTI, Azstarys, IBSRELA, The Cologuard Plus Collection Kit, Cologuard Collection Kit, MOUNJARO, JARDIANCE.
Industry payments across TX — which companies pay providers there.
